Mobile Site ›

The Use of Genetics in Guiding Therapy

Mayo CYP2C19 Test

Slide 11

June 2012

Mayo Medical Laboratories offers a test that can be ordered as an aid for predicting an individual’s response to clopidogrel. This test is the CYP2C19 sequence genotype, which is a sequencing-based assay that detects the presence of the star alleles listed here as well as any other rare variants that may occur in the regions sequenced. This test may be additionally useful for psychiatry applications, as discussed later.

Mayo CYP2C19 Test


Jump to section: